BioWorld MedTech

Jan. 22, 2014

Proteus continues momentum, receives $31.6M in venture funding

Proteus Digital Health (Redwood City, California) reported it has received $31.6 million in debt financing from Oxford Finance and Silicon Valley Bank. Read More

Covidien reports exiting its renal denervation program

Washington Roundup: FDA seeks standardized data format for filings with computational models

DePuy Synthes Spine launches new spinal fusion bone scaffold

Deals roundup: Teva Pharmaceutical in plan to acquire NuPathe for $144 million

BioWorld Survey: Let Us Know What You Think!

Financings roundup: ZipLine Medical closes C round for $4.3 million

HIT roundup: Nuance conducts study on physicians' attitudes toward clinical documentation

Patent watch: Titan Spine wins five new U.S. patents for Endoskeleton devices

Agreements/contracts: Edison launches search for therapeutic partners

Products

MDD's Oncology Extra

Today's news in brief

BioWorld

BioWorld briefs for May 21, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for May 19, 2026

Acid alpha-glucosidase molecular structure isolated on black

‘Detargeted’ targeted gene therapy improves activity in Pompe

BioWorld

A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...

WHO declares Ebola outbreak a public health emergency of international concern

BioWorld

The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...

Nxera Pharma prepares and tests new GPR17 antagonists

BioWorld Science

Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...